Clinical trials in Czechia
7,109 studies list at least one site in Czechia. 1,011 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Czechia recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Novartis Pharmaceuticals (330) · Pfizer (249) · AstraZeneca (227) · Sanofi (223) · Charles University, Czech Republic (207) · Hoffmann-La Roche (200) · GlaxoSmithKline (196) · Bayer (152)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting14
- Hyperinflammation and Hyperferritinemia in Critically Ill PatientsNov 10, 2026NCT06820905
- Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan WomenNov 10, 2026NCT07645885
- Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection FractionNov 6, 2026NCT07403058
- Middle Meningeal Artery Embolisation in Chronic Subdural HematomaNov 5, 2026NCT07751887
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
Show 9 moreShow fewer
- Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular SchwannomaOct 22, 2026NCT07130851
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsOct 21, 2026NCT04557449
- Cervical Stiffness in Women With Threatened Preterm LaborOct 21, 2026NCT07840235
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLOct 20, 2026NCT07297914
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- Mortality and Muscle Mass Loss in Critically Ill Patients.Oct 19, 2026NCT07280039
- Evaluation of the DuoVT PFA System for Ventricular TachycardiaOct 16, 2026NCT07706712
- Effects of GDHT (Goal Directed Hemodynamic Therapy) Using a Non-invasive Hemodynamic Monitoring in Elective NeurosurgeryOct 15, 2026NCT07101991
- Optimal Shock Energy for Electrical Cardioversion of Atrial FibrillationOct 13, 2026NCT07610980
First site in Czechia16
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisNov 10, 2026NCT06429176
- Hyperinflammation and Hyperferritinemia in Critically Ill PatientsNov 10, 2026NCT06820905
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNov 9, 2026NCT07621809
- An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSNov 9, 2026NCT07665437
- A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedNov 3, 2026NCT07665450
Show 11 moreShow fewer
- Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple SclerosisOct 30, 2026NCT07827586
- A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory MyopathiesOct 29, 2026NCT07789015
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent InfectionsOct 28, 2026NCT07220915
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Oct 27, 2026NCT07234032
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
- Evaluation of the DuoVT PFA System for Ventricular TachycardiaOct 16, 2026NCT07706712
- Effects of GDHT (Goal Directed Hemodynamic Therapy) Using a Non-invasive Hemodynamic Monitoring in Elective NeurosurgeryOct 15, 2026NCT07101991
- Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).Oct 13, 2026NCT06641414
- Optimal Shock Energy for Electrical Cardioversion of Atrial FibrillationOct 13, 2026NCT07610980
- A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Oct 13, 2026NCT07630974
Results posted16
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
- A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular DegenerationNov 3, 2026NCT06591598
Show 11 moreShow fewer
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)Nov 2, 2026NCT04502030
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac SurgeryOct 26, 2026NCT03954314
- Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLOct 21, 2026NCT04404283
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Oct 15, 2026NCT04701983
- Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)Oct 13, 2026NCT04893317
Stopped8
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
- Small Bowel DiversionTerminatedNov 6, 2026NCT06374368
- A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489TerminatedNov 2, 2026NCT07073820
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
- A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedOct 22, 2026NCT07222189
Show 3 moreShow fewer
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedOct 21, 2026NCT06867094
- Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedOct 16, 2026NCT05070845
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedOct 13, 2026NCT06637631
Newly registered23
- External vs. Internal Focus During Abdominal Bracing in Low Back PainNov 10, 2026NCT07928518
- The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial FibrillationNov 9, 2026NCT07925359
- Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After Electrophysiology Procedures (GLUE-EP)Nov 9, 2026NCT07926191
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- Intermittent Fasting and Anthropometric ParametersNov 3, 2026NCT07912255
Show 18 moreShow fewer
- Early Detection of Familial Hypercholesterolaemia in Pre-school Children ( CzeCH-IT)Nov 3, 2026NCT07912281
- The Immediate Effect of Motor Imagery on Functional Upper Limb Movement in Stroke Survivors Assessed Using Surface Electromyography and Kinematic AnalysisNov 3, 2026NCT07912762
- Resistive Versus Forced-Air Warming for Prevention of Perioperative HypothermiaNov 2, 2026NCT07909252
- AKU Study - Acupuncture for Aromatase Inhibitor-Induced Musculoskeletal SyndromeNov 2, 2026NCT07909785
- Ultrasound-Guided Radiofrequency Ablation for Focal AdenomyosisOct 30, 2026NCT07906535
- Standardized 4D Transperineal Ultrasound Assessment of Urethrovesical Junction Mobility After Vaginal Laser Treatment for Stress Urinary Incontinence.Oct 30, 2026NCT07907016
- Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSEOct 29, 2026NCT07902739
- Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal DisordersOct 29, 2026NCT07903142
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Vacuum Compression Therapy and Tissue Oxygenation in Chronic Leg UlcersOct 28, 2026NCT07901517
- Anti-Müllerian Hormone in Breast Cancer Clinical PracticeOct 27, 2026NCT07896772
- MRD Monitoring in Colorectal Cancer Using ctDNAOct 26, 2026NCT07895459
- Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in ChildrenOct 23, 2026NCT07891832
- Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's DiseaseOct 20, 2026NCT07884045
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasEOct 14, 2026NCT07874139
- Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a SystemOct 13, 2026NCT07870265
- Multimodal Machine Learning for Predicting Reduced Participation in Elite Youth FootballOct 13, 2026NCT07870460
- To Assess Self-sufficiency in Parkinson's Patients and How Rehabilitation Affects Symptoms Linked to IndependenceOct 13, 2026NCT07872202
Studies
Recruiting first, then most recently updated. Showing 50 of 7,109 — search for more.
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)Enrolling by invitationNCT07161700Phase 2
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisRecruitingNCT06429176Phase 2
- A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaRecruitingNCT05562466Phase 3
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingNCT06651281Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsRecruitingNCT04557449Phase 2
- Non-invasive Brain Tumor Molecular Diagnostics and MonitoringRecruitingNCT06501521
- Hyperinflammation and Hyperferritinemia in Critically Ill PatientsRecruitingNCT06820905
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational StudyRecruitingNCT07112937
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)RecruitingNCT07234032Phase 3
- Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan WomenRecruitingNCT07645885Not applicable
- A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT07540221Phase 3
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)RecruitingNCT07065240Phase 2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingNCT07555938Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)RecruitingNCT07366034Phase 3
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3
- A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)RecruitingNCT07405151Phase 1/2
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)RecruitingNCT07276724Phase 3
- A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)RecruitingNCT07058077Phase 2/3
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisRecruitingNCT07067463Phase 3
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)RecruitingNCT07318558Phase 3
- An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007Enrolling by invitationNCT06075537Phase 2/3
- Trifecta-Heart cfDNA-MMDx StudyRecruitingNCT04707872
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 2
- Asciminib Roll-over StudyRecruitingNCT04877522Phase 4
- The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial FibrillationNot yet recruitingNCT07925359Not applicable
- Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).RecruitingNCT06133972Phase 3
- Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After Electrophysiology Procedures (GLUE-EP)Not yet recruitingNCT07926191
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruitingNCT06237452Phase 3
- Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)RecruitingNCT06711887Phase 3
- Secukinumab Open Label Roll-over Extension ProtocolRecruitingNCT04638647Phase 4
- Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruitingNCT06865105Phase 2
- A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruitingNCT07441642Phase 2
- An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSRecruitingNCT07665437Phase 3
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruitingNCT07621809Phase 3
- Remibrutinib Open Label Roll-over Post-trial Access ProtocolRecruitingNCT07456891Phase 3